Literature DB >> 18035074

Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction.

Joshua W Knowles1, Huijan Wang, Haruka Itakura, Audrey Southwick, Richard M Myers, Carlos Iribarren, Stephen P Fortmann, Alan S Go, Thomas Quertermous, Mark A Hlatky.   

Abstract

BACKGROUND: Genetic polymorphisms may affect the balance between coagulation and fibrinolysis and thereby affect individual vulnerability to acute myocardial infarction (MI) among patients with underlying coronary atherosclerosis.
METHODS: We enrolled 1375 patients with an initial clinical presentation of coronary disease. We genotyped 49 single nucleotide polymorphisms (SNPs) in 9 coagulation system genes and compared patients who had an initial acute MI with patients who presented with stable exertional angina.
RESULTS: An SNP in CD36 (rs3211956) was significantly (P = .04) more common among patients who presented with acute MI (minor allele frequency 10.5%) than patients with stable exertional angina (minor allele frequency 8.0%). This association became marginally significant, however, after adjustment for conventional cardiac risk factors in an additive genetic model (odds ratio 1.34, CI 1.00-1.88, P = .053). An SNP in ITGB3 (Leu59Pro, rs5918) was slightly, but not significantly (P = .083), more common among patients with acute MI (minor allele frequency 14.5%) than among patients with stable exertional angina (minor allele frequency 12.0%). Two linked SNPs in THBD (Ala473Val, rs1042579; and rs3176123) were slightly, but not significantly (P = .079 and 0.052, respectively), less common among patients with acute MI (minor allele frequency 16.1%) than among patients with stable exertional angina (18.7% and 19.0%, respectively).
CONCLUSIONS: Four SNPs in platelet glycoprotein and hemostatic genes were nominally associated with acute MI rather than stable exertional angina as the initial clinical presentation of coronary artery disease. These findings are suggestive but require independent confirmation in larger studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18035074      PMCID: PMC4031914          DOI: 10.1016/j.ahj.2007.05.021

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  48 in total

Review 1.  Candidate-gene approaches for studying complex genetic traits: practical considerations.

Authors:  Holly K Tabor; Neil J Risch; Richard M Myers
Journal:  Nat Rev Genet       Date:  2002-05       Impact factor: 53.242

Review 2.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

Authors:  M Febbraio; D P Hajjar; R L Silverstein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Polymorphisms of genes affecting thrombosis and risk of myocardial infarction.

Authors:  S Kakko; T Elo; J M Tapanainen; H V Huikuri; M J Savolainen
Journal:  Eur J Clin Invest       Date:  2002-09       Impact factor: 4.686

4.  Tissue-type plasminogen activator -7,351C/T enhancer polymorphism is associated with a first myocardial infarction.

Authors:  Per Ladenvall; Lars Johansson; Jan-Håkan Jansson; Sverker Jern; Torbjörn K Nilsson; Anna Tjärnlund; Christina Jern; Kurt Boman
Journal:  Thromb Haemost       Date:  2002-01       Impact factor: 5.249

5.  Prediction of the risk of myocardial infarction from polymorphisms in candidate genes.

Authors:  Yoshiji Yamada; Hideo Izawa; Sahoko Ichihara; Fumimaro Takatsu; Hitoshi Ishihara; Haruo Hirayama; Takahito Sone; Masashi Tanaka; Mitsuhiro Yokota
Journal:  N Engl J Med       Date:  2002-12-12       Impact factor: 91.245

6.  Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review.

Authors:  S M Boekholdt; N R Bijsterveld; A H Moons; M Levi; H R Büller; R J Peters
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

7.  Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases.

Authors:  A H Wu; G J Tsongalis
Journal:  Am J Cardiol       Date:  2001-06-15       Impact factor: 2.778

8.  Platelet glycoprotein IIb polymorphism, traditional risk factors and non-fatal myocardial infarction in young women.

Authors:  A P Reiner; S M Schwartz; P N Kumar; F R Rosendaal; R M Pearce; K M Aramaki; B M Psaty; D S Siscovick
Journal:  Br J Haematol       Date:  2001-03       Impact factor: 6.998

9.  The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction.

Authors:  P F Bray; C P Cannon; P Goldschmidt-Clermont; L A Moyé; M A Pfeffer; F M Sacks; E Braunwald
Journal:  Am J Cardiol       Date:  2001-08-15       Impact factor: 2.778

10.  No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age.

Authors: 
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

View more
  23 in total

1.  Pathway-based genome-wide association analysis of coronary heart disease identifies biologically important gene sets.

Authors:  Lisa de las Fuentes; Wei Yang; Victor G Dávila-Román; C Charles Gu
Journal:  Eur J Hum Genet       Date:  2012-04-18       Impact factor: 4.246

2.  Vav family Rho guanine nucleotide exchange factors regulate CD36-mediated macrophage foam cell formation.

Authors:  S Ohidar Rahaman; Wojciech Swat; Maria Febbraio; Roy L Silverstein
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

3.  CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs.

Authors:  Wei Li; Maria Febbraio; Sekhar P Reddy; Dae-Yeul Yu; Masayuki Yamamoto; Roy L Silverstein
Journal:  J Clin Invest       Date:  2010-10-11       Impact factor: 14.808

4.  Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms.

Authors:  Arunima Ghosh; Gurunathan Murugesan; Kan Chen; Li Zhang; Qing Wang; Maria Febbraio; Rita Marie Anselmo; Kandice Marchant; John Barnard; Roy L Silverstein
Journal:  Blood       Date:  2011-04-08       Impact factor: 22.113

Review 5.  CD36 genetics and the metabolic complications of obesity.

Authors:  Latisha Love-Gregory; Nada A Abumrad
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-11       Impact factor: 4.294

6.  Systems analysis of gene ontology and biological pathways involved in post-myocardial infarction responses.

Authors:  Nguyen T Nguyen; Merry L Lindsey; Yu-Fang Jin
Journal:  BMC Genomics       Date:  2015-06-11       Impact factor: 3.969

7.  A genome-wide association study of variations in maternal cardiometabolic genes and risk of placental abruption.

Authors:  Amy Moore; Daniel A Enquobahrie; Sixto E Sanchez; Cande V Ananth; Percy N Pacora; Michelle A Williams
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

8.  Teaching an old dog new tricks: potential antiatherothrombotic use for statins.

Authors:  Roy L Silverstein
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

9.  Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile.

Authors:  Latisha Love-Gregory; Richard Sherva; Timothy Schappe; Jian-Shen Qi; Jennifer McCrea; Samuel Klein; Margery A Connelly; Nada A Abumrad
Journal:  Hum Mol Genet       Date:  2010-10-08       Impact factor: 6.150

10.  Association of platelet ITGA2B and ITGB3 polymorphisms with ex vivo antiplatelet effect of ticagrelor in healthy Chinese male subjects.

Authors:  Mu-Peng Li; Yan Xiong; An Xu; Ji-Peng Zhou; Jie Tang; Zan-Ling Zhang; Hong-Hao Zhou; Wei Zhang; Xiao-Ping Chen
Journal:  Int J Hematol       Date:  2014-01-29       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.